image
Healthcare - Medical - Care Facilities - NASDAQ - US
$ 37.82
-3.91 %
$ 3.51 B
Market Cap
12.4
P/E
1. INTRINSIC VALUE

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.[ Read More ]

The intrinsic value of one ACHC stock under the base case scenario is HIDDEN Compared to the current market price of 37.8 USD, Acadia Healthcare Company, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart ACHC

image
FINANCIALS
2.93 B REVENUE
12.20%
507 M OPERATING INCOME
14.12%
-21.7 M NET INCOME
-7.74%
462 M OPERATING CASH FLOW
21.49%
-397 M INVESTING CASH FLOW
-29.88%
-62.7 M FINANCING CASH FLOW
43.47%
816 M REVENUE
2.46%
147 M OPERATING INCOME
3.15%
71.4 M NET INCOME
-9.06%
163 M OPERATING CASH FLOW
-4.69%
-193 M INVESTING CASH FLOW
-24.16%
34.9 M FINANCING CASH FLOW
320.89%
Balance Sheet Decomposition Acadia Healthcare Company, Inc.
image
Current Assets 596 M
Cash & Short-Term Investments 100 M
Receivables 430 M
Other Current Assets 66.4 M
Non-Current Assets 4.76 B
Long-Term Investments 0
PP&E 2.38 B
Other Non-Current Assets 2.38 B
Current Liabilities 886 M
Accounts Payable 156 M
Short-Term Debt 56.5 M
Other Current Liabilities 673 M
Non-Current Liabilities 1.59 B
Long-Term Debt 1.45 B
Other Non-Current Liabilities 131 M
EFFICIENCY
Earnings Waterfall Acadia Healthcare Company, Inc.
image
Revenue 2.93 B
Cost Of Revenue 2.25 B
Gross Profit 683 M
Operating Expenses 176 M
Operating Income 507 M
Other Expenses 528 M
Net Income -21.7 M
RATIOS
23.31% GROSS MARGIN
23.31%
17.30% OPERATING MARGIN
17.30%
-0.74% NET MARGIN
-0.74%
-0.78% ROE
-0.78%
-0.40% ROA
-0.40%
7.53% ROIC
7.53%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Acadia Healthcare Company, Inc.
image
Net Income -21.7 M
Depreciation & Amortization 132 M
Capital Expenditures -424 M
Stock-Based Compensation 32.3 M
Change in Working Capital 6.63 M
Others 435 M
Free Cash Flow 38.2 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Acadia Healthcare Company, Inc.
image
Wall Street analysts predict an average 1-year price target for ACHC of $80 , with forecasts ranging from a low of $70 to a high of $94 .
ACHC Lowest Price Target Wall Street Target
70 USD 85.09%
ACHC Average Price Target Wall Street Target
80 USD 111.53%
ACHC Highest Price Target Wall Street Target
94 USD 148.55%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Acadia Healthcare Company, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
402 K USD 2
9-12 MONTHS
10.2 M USD 2
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
8 months ago
Mar 05, 2024
Sell 188 K USD
Miquelon Wade D
Director
- 2203
85.39 USD
8 months ago
Mar 04, 2024
Sell 214 K USD
Gregg Vicky B
Director
- 2500
85.56 USD
11 months ago
Dec 12, 2023
Sell 610 K USD
OSTEEN DEBRA K
Director
- 8000
76.23 USD
11 months ago
Dec 13, 2023
Sell 2.72 M USD
OSTEEN DEBRA K
Director
- 35000
77.67 USD
1 year ago
Nov 14, 2023
Sell 1.11 M USD
Hollinsworth John S.
EVP of Operations
- 15000
74 USD
1 year ago
Nov 14, 2023
Sell 1.1 M USD
Hollinsworth John S.
EVP of Operations
- 15000
73.66 USD
1 year ago
Nov 14, 2023
Sell 1.1 M USD
Hollinsworth John S.
EVP of Operations
- 15000
73.51 USD
1 year ago
Nov 14, 2023
Sell 1.48 M USD
Hollinsworth John S.
EVP of Operations
- 20000
74 USD
1 year ago
Nov 14, 2023
Sell 2.05 M USD
Hollinsworth John S.
EVP of Operations
- 27500
74.5 USD
1 year ago
Nov 08, 2023
Sell 931 K USD
Hollinsworth John S.
EVP of Operations
- 12500
74.5 USD
1 year ago
Nov 10, 2023
Sell 1.46 M USD
Hollinsworth John S.
EVP of Operations
- 20000
73 USD
1 year ago
Nov 08, 2023
Sell 1.11 M USD
OSTEEN DEBRA K
Director
- 15000
74.21 USD
2 years ago
Sep 07, 2022
Sell 413 K USD
GRIECO WILLIAM
Director
- 5000
82.54 USD
2 years ago
Aug 04, 2022
Sell 870 K USD
Hollinsworth John S.
EVP of Operations
- 10780
80.68 USD
2 years ago
Aug 04, 2022
Sell 8.1 K USD
Duckworth David M.
Chief Financial Officer
- 100
81 USD
2 years ago
Aug 04, 2022
Sell 2.16 M USD
Duckworth David M.
Chief Financial Officer
- 26821
80.63 USD
2 years ago
Aug 04, 2022
Sell 688 K USD
Howard Christopher L
EVP, GC and Secretary
- 8443
81.51 USD
2 years ago
Aug 04, 2022
Sell 998 K USD
Howard Christopher L
EVP, GC and Secretary
- 12214
81.67 USD
2 years ago
Jul 29, 2022
Sell 501 K USD
Petrie William M
director:
- 6000
83.42 USD
3 years ago
Jun 14, 2021
Sell 1.83 M USD
WAUD REEVE B
Director
- 27515
66.47 USD
3 years ago
Jun 14, 2021
Sell 1.83 M USD
WAUD REEVE B
Director
- 27515
66.47 USD
3 years ago
Jun 14, 2021
Sell 332 K USD
Hollinsworth John S.
EVP of Operations
- 5000
66.31 USD
3 years ago
Mar 12, 2021
Sell 118 K USD
GRIECO WILLIAM
Director
- 2000
59.02 USD
3 years ago
Mar 15, 2021
Sell 121 K USD
GRIECO WILLIAM
Director
- 2000
60.65 USD
3 years ago
Mar 12, 2021
Sell 6.47 M USD
WAUD REEVE B
Director
- 109443
59.1208 USD
3 years ago
Mar 11, 2021
Sell 1.09 M USD
Duckworth David M.
Chief Financial Officer
- 18780
58.04 USD
3 years ago
Mar 11, 2021
Sell 1.93 M USD
Howard Christopher L
EVP, GC and Secretary
- 33228
58.09 USD
4 years ago
Jun 12, 2020
Sell 861 K USD
WAUD REEVE B
Director
- 33333
25.8416 USD
4 years ago
Jun 12, 2020
Sell 2.3 M USD
WAUD REEVE B
Director
- 88978
25.8833 USD
5 years ago
Sep 05, 2019
Bought 531 K USD
OSTEEN DEBRA K
Chief Executive Officer
+ 20000
26.533 USD
6 years ago
Nov 01, 2018
Sell 1.88 M USD
WAUD REEVE B
Director
- 41865
45 USD
6 years ago
Jul 26, 2018
Sell 366 K USD
WAUD REEVE B
Director
- 8135
45 USD
6 years ago
Mar 14, 2018
Sell 16.6 K USD
GOLDBERG RANDALL P
VP of Business Development
- 400
41.4714 USD
6 years ago
Mar 15, 2018
Sell 324 K USD
WAUD REEVE B
Director
- 7698
42.03 USD
6 years ago
Mar 12, 2018
Sell 1.55 M USD
WAUD REEVE B
Director
- 36902
42.02 USD
6 years ago
Mar 13, 2018
Sell 227 K USD
WAUD REEVE B
Director
- 5400
42.04 USD
6 years ago
Mar 02, 2018
Sell 669 K USD
WAUD REEVE B
Director
- 17750
37.69 USD
6 years ago
Mar 02, 2018
Sell 2.68 M USD
WAUD REEVE B
Director
- 70141
38.19 USD
6 years ago
Mar 02, 2018
Sell 2.41 M USD
WAUD REEVE B
Director
- 61029
39.49 USD
6 years ago
Mar 02, 2018
Sell 43.1 K USD
WAUD REEVE B
Director
- 1080
39.92 USD
6 years ago
Mar 06, 2018
Sell 2 M USD
WAUD REEVE B
Director
- 50000
40.07 USD
6 years ago
Mar 01, 2018
Sell 15.4 K USD
GOLDBERG RANDALL P
VP of Business Development
- 400
38.47 USD
6 years ago
Mar 01, 2018
Sell 21.5 K USD
GOLDBERG RANDALL P
VP of Business Development
- 560
38.4632 USD
6 years ago
Dec 15, 2017
Sell 3.18 M USD
WAUD REEVE B
Director
- 100000
31.797 USD
7 years ago
Aug 22, 2017
Sell 50.6 M USD
Gordon Christopher R
Director
- 998438
50.69 USD
7 years ago
Aug 22, 2017
Sell 49.9 M USD
WAUD REEVE B
Director
- 984075
50.69 USD
7 years ago
Aug 22, 2017
Sell 15.2 M USD
JACOBS JOEY A
Chief Executive Officer
- 300000
50.69 USD
7 years ago
Aug 22, 2017
Sell 10.1 M USD
JACOBS JOEY A
Chief Executive Officer
- 200000
50.69 USD
7 years ago
Aug 22, 2017
Sell 2.53 M USD
Fincher Ronald Morgan
Chief Operating Officer
- 50000
50.69 USD
7 years ago
Aug 22, 2017
Sell 1.52 M USD
Fincher Ronald Morgan
Chief Operating Officer
- 30000
50.69 USD
7 years ago
Aug 22, 2017
Sell 2.72 M USD
Howard Christopher L
EVP, GC and Secretary
- 53713
50.69 USD
7 years ago
Aug 22, 2017
Sell 10.5 M USD
TURNER BRENT
President
- 206252
50.69 USD
7 years ago
Aug 11, 2017
Sell 51.7 K USD
GRIECO WILLIAM
Director
- 1000
51.675 USD
7 years ago
Aug 11, 2017
Sell 51.7 K USD
GRIECO WILLIAM
Director
- 1000
51.745 USD
7 years ago
Aug 03, 2017
Sell 880 K USD
Howard Christopher L
EVP, GC and Secretary
- 16762
52.4734 USD
7 years ago
Aug 03, 2017
Sell 880 K USD
Howard Christopher L
EVP, GC and Secretary
- 16762
52.4734 USD
7 years ago
Jul 31, 2017
Sell 71.3 K USD
Schwieger Scott
Chief Compliance Officer
- 1350
52.8372 USD
7 years ago
Jul 31, 2017
Sell 52.8 K USD
Schwieger Scott
Chief Compliance Officer
- 1000
52.8365 USD
7 years ago
Jul 31, 2017
Sell 28.6 K USD
Schwieger Scott
Chief Compliance Officer
- 541
52.9106 USD
7 years ago
Jul 31, 2017
Sell 127 M USD
Gordon Christopher R
Director
- 2453764
51.65 USD
7 years ago
Jul 28, 2017
Sell 1.84 M USD
WAUD REEVE B
Director
- 34600
53.13 USD
7 years ago
Jul 28, 2017
Sell 826 K USD
WAUD REEVE B
Director
- 15400
53.63 USD
7 years ago
Jul 31, 2017
Sell 61.5 M USD
WAUD REEVE B
Director
- 1190000
51.65 USD
7 years ago
Jul 05, 2017
Sell 2.5 M USD
WAUD REEVE B
Director
- 50000
50.043 USD
7 years ago
Jun 22, 2017
Sell 2.38 M USD
WAUD REEVE B
Director
- 50000
47.512 USD
7 years ago
Jun 16, 2017
Sell 45.4 K USD
GRIECO WILLIAM
Director
- 1000
45.4364 USD
7 years ago
Jun 16, 2017
Sell 45.4 K USD
GRIECO WILLIAM
Director
- 1000
45.4068 USD
7 years ago
Jun 14, 2017
Sell 33 M USD
WAUD REEVE B
Director
- 724694
45.53 USD
7 years ago
Jun 09, 2017
Sell 2.25 M USD
WAUD REEVE B
Director
- 50000
45.087 USD
7 years ago
May 04, 2017
Sell 223 K USD
GOLDBERG RANDALL P
VP of Business Development
- 4925
45.18 USD
7 years ago
May 02, 2017
Sell 1.86 M USD
Fincher Ronald Morgan
Chief Operating Officer
- 41483
44.94 USD
7 years ago
May 01, 2017
Sell 1.98 M USD
Fincher Ronald Morgan
Chief Operating Officer
- 45000
43.96 USD
7 years ago
Mar 15, 2017
Sell 122 M USD
WAUD REEVE B
Director
- 2973773
41.06 USD
7 years ago
Mar 15, 2017
Sell 2.1 M USD
WAUD REEVE B
Director
- 51118
41.06 USD
7 years ago
Mar 10, 2017
Sell 42.6 K USD
GRIECO WILLIAM
Director
- 1000
42.56 USD
7 years ago
Mar 07, 2017
Sell 44.2 K USD
Schwieger Scott
Chief Compliance Officer
- 1012
43.67 USD
7 years ago
Mar 08, 2017
Sell 39.8 K USD
GOLDBERG RANDALL P
VP of Business Development
- 914
43.5466 USD
7 years ago
Mar 02, 2017
Sell 44.6 K USD
GRIECO WILLIAM
Director
- 1000
44.64 USD
8 years ago
Aug 02, 2016
Sell 155 K USD
Schwieger Scott
Chief Compliance Officer
- 3000
51.67 USD
8 years ago
Aug 12, 2016
Sell 111 K USD
Schwieger Scott
Chief Compliance Officer
- 2126
52.37 USD
7 years ago
Dec 15, 2016
Sell 171 K USD
WAUD REEVE B
Director
- 5087
33.67 USD
7 years ago
Dec 15, 2016
Sell 305 K USD
WAUD REEVE B
Director
- 8913
34.23 USD
7 years ago
Dec 16, 2016
Sell 492 K USD
WAUD REEVE B
Director
- 14000
35.14 USD
7 years ago
Dec 12, 2016
Sell 501 K USD
WAUD REEVE B
Director
- 14000
35.79 USD
7 years ago
Dec 13, 2016
Sell 308 K USD
WAUD REEVE B
Director
- 8841
34.86 USD
7 years ago
Dec 13, 2016
Sell 183 K USD
WAUD REEVE B
Director
- 5159
35.51 USD
7 years ago
Dec 14, 2016
Sell 442 K USD
WAUD REEVE B
Director
- 13300
33.2 USD
7 years ago
Dec 14, 2016
Sell 23.7 K USD
WAUD REEVE B
Director
- 700
33.88 USD
8 years ago
Sep 14, 2016
Sell 4.21 M USD
WAUD CAPITAL PARTNERS II, L.L.C.
10 percent owner
- 83861
50.19 USD
8 years ago
Sep 15, 2016
Sell 11 M USD
WAUD CAPITAL PARTNERS II, L.L.C.
10 percent owner
- 223640
49.24 USD
8 years ago
Sep 16, 2016
Sell 24.9 M USD
WAUD CAPITAL PARTNERS II, L.L.C.
10 percent owner
- 521033
47.74 USD
8 years ago
Sep 14, 2016
Sell 4.21 M USD
WAUD REEVE B
Director
- 83861
50.19 USD
8 years ago
Sep 14, 2016
Sell 2.32 M USD
WAUD REEVE B
Director
- 46302
50.19 USD
8 years ago
Sep 15, 2016
Sell 11 M USD
WAUD REEVE B
Director
- 223640
49.24 USD
8 years ago
Sep 15, 2016
Sell 6.08 M USD
WAUD REEVE B
Director
- 123473
49.24 USD
8 years ago
Sep 16, 2016
Sell 24.9 M USD
WAUD REEVE B
Director
- 521033
47.74 USD
8 years ago
Sep 16, 2016
Sell 13.7 M USD
WAUD REEVE B
Director
- 287668
47.74 USD
8 years ago
Sep 16, 2016
Sell 3.81 M USD
WAUD REEVE B
Director
- 75000
50.76 USD
8 years ago
Sep 14, 2016
Sell 2.32 M USD
WAUD CAPITAL PARTNERS III, L.L.C.
10 percent owner
- 46302
50.19 USD
8 years ago
Sep 15, 2016
Sell 6.08 M USD
WAUD CAPITAL PARTNERS III, L.L.C.
10 percent owner
- 123473
49.24 USD
8 years ago
Sep 16, 2016
Sell 13.7 M USD
WAUD CAPITAL PARTNERS III, L.L.C.
10 percent owner
- 287668
47.74 USD
8 years ago
Sep 12, 2016
Sell 1.38 M USD
WAUD CAPITAL PARTNERS III, L.L.C.
10 percent owner
- 26679
51.77 USD
8 years ago
Sep 13, 2016
Sell 168 K USD
WAUD CAPITAL PARTNERS III, L.L.C.
10 percent owner
- 3275
51.23 USD
8 years ago
Sep 12, 2016
Sell 2.5 M USD
WAUD CAPITAL PARTNERS II, L.L.C.
10 percent owner
- 48321
51.77 USD
8 years ago
Sep 13, 2016
Sell 304 K USD
WAUD CAPITAL PARTNERS II, L.L.C.
10 percent owner
- 5933
51.23 USD
8 years ago
Sep 12, 2016
Sell 2.5 M USD
WAUD REEVE B
director, 10 percent owner:
- 48321
51.77 USD
8 years ago
Sep 12, 2016
Sell 1.38 M USD
WAUD REEVE B
director, 10 percent owner:
- 26679
51.77 USD
8 years ago
Sep 13, 2016
Sell 304 K USD
WAUD REEVE B
director, 10 percent owner:
- 5933
51.23 USD
8 years ago
Sep 13, 2016
Sell 168 K USD
WAUD REEVE B
director, 10 percent owner:
- 3275
51.23 USD
8 years ago
Aug 15, 2016
Sell 906 K USD
Duckworth David M.
Chief Financial Officer
- 16670
54.33 USD
8 years ago
Aug 11, 2016
Sell 525 K USD
Fincher Ronald Morgan
Chief Operating Officer
- 10000
52.5 USD
8 years ago
Aug 12, 2016
Sell 242 K USD
Fincher Ronald Morgan
Chief Operating Officer
- 4604
52.5 USD
8 years ago
Aug 08, 2016
Sell 463 K USD
Fincher Ronald Morgan
Chief Operating Officer
- 8800
52.5609 USD
8 years ago
Aug 05, 2016
Sell 42.7 K USD
GOLDBERG RANDALL P
10 percent owner
- 814
52.44 USD
8 years ago
Aug 05, 2016
Sell 52.4 K USD
GOLDBERG RANDALL P
10 percent owner
- 1000
52.436 USD
8 years ago
Aug 05, 2016
Sell 26.4 K USD
GOLDBERG RANDALL P
10 percent owner
- 504
52.3831 USD
8 years ago
Aug 05, 2016
Sell 68.5 K USD
GOLDBERG RANDALL P
10 percent owner
- 1308
52.3861 USD
8 years ago
Nov 24, 2015
Sell 523 K USD
DODD FRED THOMAS JR
10 percent owner
- 7469
70 USD
9 years ago
Nov 05, 2015
Sell 1.49 M USD
DODD FRED THOMAS JR
Director
- 20879
71.4273 USD
9 years ago
Nov 06, 2015
Sell 209 K USD
GOLDBERG RANDALL P
10 percent owner
- 2824
74.0104 USD
9 years ago
Nov 06, 2015
Sell 1.11 M USD
CARPENTER DANNY E
10 percent owner
- 15000
74.0203 USD
9 years ago
Aug 14, 2015
Sell 2.5 M USD
Duckworth David M.
Chief Financial Officer
- 31129
80.47 USD
9 years ago
Aug 14, 2015
Sell 4.02 M USD
JACOBS JOEY A
Chief Executive Officer
- 50000
80.47 USD
9 years ago
Aug 14, 2015
Sell 3.39 M USD
JACOBS JOEY A
Chief Executive Officer
- 42066
80.47 USD
9 years ago
Aug 14, 2015
Sell 1.76 M USD
Fincher Ronald Morgan
Chief Operating Officer
- 21888
80.47 USD
9 years ago
Aug 14, 2015
Sell 1.24 M USD
Fincher Ronald Morgan
Chief Operating Officer
- 15406
80.47 USD
9 years ago
Aug 14, 2015
Sell 1.63 M USD
POLSON JACK E
10 percent owner
- 20230
80.47 USD
10 years ago
May 02, 2014
Sell 46 K USD
GOLDBERG RANDALL P
10 percent owner
- 1016
45.25 USD
9 years ago
Aug 14, 2015
Sell 58.2 K USD
GOLDBERG RANDALL P
10 percent owner
- 723
80.47 USD
9 years ago
Mar 02, 2015
Sell 25.8 K USD
GOLDBERG RANDALL P
10 percent owner
- 392
65.82 USD
11 years ago
Jun 14, 2013
Sell 681 K USD
SHEAR BRUCE A
Executive Vice Chairman
- 20000
34.05 USD
9 years ago
Aug 14, 2015
Sell 688 K USD
SHEAR BRUCE A
Executive Vice Chairman
- 8555
80.47 USD
9 years ago
Aug 14, 2015
Sell 2.91 M USD
Howard Christopher L
EVP, GC and Secretary
- 36141
80.47 USD
10 years ago
Nov 05, 2014
Sell 7.96 K USD
DODD FRED THOMAS JR
10 percent owner
- 132
60.33 USD
7. News
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Acadia Healthcare Company, Inc. - ACHC NEW YORK, NY / ACCESSWIRE / November 16, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. accesswire.com - 12 hours ago
The Schall Law Firm Wants Shareholders With Losses To Join A Securities Fraud Case Against Acadia Healthcare Company Inc LOS ANGELES, CA / ACCESSWIRE / November 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 28, 2020 and September 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 16, 2024. accesswire.com - 13 hours ago
ACHC FRAUD ALERT: Suffer Losses on Your Acadia Healthcare Securities? Contact BFA Law before December 16 Securities Fraud Class Action Deadline (Nasdaq:ACHC) Acadia Healthcare Company, Inc. investors that lost money on their investment are encouraged to contact BFA Law before December 16, 2024 legal deadline. globenewswire.com - 18 hours ago
ACADIA HEALTHCARE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Acadia Healthcare Company, Inc. - ACHC NEW ORLEANS , Nov. 15, 2024 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 16, 2024 to file lead plaintiff applications in a securities class action lawsuit against Acadia Healthcare Company, Inc. (NasdaqGS: ACHC), if they purchased the Company's securities between February 28, 2020 and October 18, 2024, inclusive (the "Class Period").  This action is pending in the United States District Court for the Middle District of Tennessee. prnewswire.com - 1 day ago
Acadia Healthcare Company, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. December 16, 2024 Deadline to file Lead Plaintiff Motion Investors can contact the law firm at no cost to learn more about recovering their losses Investors can contact the law firm at no cost to learn more about recovering their losses globenewswire.com - 1 day ago
Acadia Healthcare (ACHC) Class Period Expanded After NYT Report That Veterans Affairs Department Is Investigating Allegations of Holding Patients Longer Than Is Medically Necessary – Hagens Berman SAN FRANCISCO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Acadia Healthcare Company (NASDAQ: ACHC) is facing securities class-action lawsuits by investors alleging the company misled them about its business practices. The more recent lawsuit filed on October 29, 2024 expanded the Class Period to end on Oct. 18, 2024 after The New York Times reported that the Veterans Affairs Department has opened an investigation into Acadia, news which sent the price of Acadia shares sharply lower on Oct. 18, 2024. globenewswire.com - 1 day ago
ROSEN, THE FIRST FILING FIRM, Encourages Acadia Healthcare Company, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ACHC NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) between February 28, 2020 and October 18, 2024, both dates inclusive (the “Class Period”) of the important December 16, 2024 lead plaintiff deadline in the securities class action first filed by the Firm. globenewswire.com - 1 day ago
Acadia Healthcare Company, Inc. Is Being Sued For Violating Securities Regulations And Affected Investors Are Urged To Contact The Schall Law Firm LOS ANGELES, CA / ACCESSWIRE / November 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 28, 2020 and September 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 16, 2024. accesswire.com - 1 day ago
Lowey Dannenberg Notifies Acadia Healthcare Company, Inc. (“Acadia Healthcare”, or the “Company”) (NASDAQ: ACHC) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Acadia Healthcare Company, Inc. (“Acadia Healthcare”, or the “Company”) (NASDAQ: ACHC) for violations of the federal securities laws on behalf of investors who purchased or acquired Acadia Healthcare common stock between February 28, 2020 and October 18, 2024, inclusive (the “Class Period”). globenewswire.com - 1 day ago
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Acadia Healthcare Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Acadia Healthcare To Contact Him Directly To Discuss Their Options globenewswire.com - 1 day ago
ACHC COURT ALERT: ACADIA HEALTHCARE (ACHC) Investors that Suffered Losses are Alerted of a Pending Class Action - Contact BFA Law before December 16 Court Deadline NEW YORK, NY / ACCESSWIRE / November 15, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Acadia Healthcare Company, Inc. (NASDAQ:ACHC) and certain of the Company's senior executives. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/acadia-healthcare-company-inc Investors have until December 16, 2024 to ask the Court to be appointed to lead the case. accesswire.com - 1 day ago
ACHC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Acadia Healthcare Company, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! NEW YORK, NY / ACCESSWIRE / November 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020, and October 18, 2024, inclusive (the "Class Period"). accesswire.com - 1 day ago
8. Profile Summary

Acadia Healthcare Company, Inc. ACHC

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 3.51 B
Dividend Yield 0.00%
Description Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.
Contact 6100 Tower Circle, Franklin, TN, 37067 https://www.acadiahealthcare.com
IPO Date March 4, 1994
Employees 17000
Officers Mr. Brett Bearfield Senior Vice President of Business Transformation Ms. Gretchen Hommrich Vice President of Investor Relations Mr. John S. Hollinsworth Advisor Ms. Isa Diaz Senior Vice President of Strategic Affairs Dr. Nasser Khan M.D. Chief Operating Officer Mr. Mark Palmenter Chief Marketing Officer Ms. Heather Dixon CPA Chief Financial Officer Mr. Andrew Lynch Chief Strategy Officer Ms. Laura Groschen Chief Information Officer Mr. Christopher Howal Hunter Chief Executive Officer & Director